Detalles de la búsqueda
1.
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
Br J Haematol
; 204(3): 849-860, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37996986
2.
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Hematol Oncol
; 42(3): e3272, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38595316
3.
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma.
Blood
; 136(22): 2548-2556, 2020 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32584959
4.
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Hematol Oncol
; 40(4): 667-677, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142384
5.
[Current status and future prospects of diffuse large B-cell lymphoma treatment].
Rinsho Ketsueki
; 63(9): 1126-1134, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-36198538
6.
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B-cell lymphoma.
Cancer Sci
; 112(7): 2845-2854, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33942442
7.
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(4): 593-602, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32171071
8.
Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Blood
; 131(23): 2528-2540, 2018 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29602763
9.
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Haematologica
; 105(9): 2308-2315, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33054055
10.
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
Ann Hematol
; 98(7): 1647-1655, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31001658
11.
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Cancer Sci
; 109(6): 2056-2062, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29601137
12.
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Cancer Sci
; 114(6): 2689-2691, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36929591
13.
[Treatment of NK/T-cell lymphoma: current situations and prospectives].
Rinsho Ketsueki
; 59(5): 588-593, 2018.
Artículo
en Japonés
| MEDLINE | ID: mdl-29877250
14.
[Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab].
Rinsho Ketsueki
; 59(2): 178-181, 2018.
Artículo
en Japonés
| MEDLINE | ID: mdl-29515070
15.
MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
Cancer
; 123(7): 1166-1173, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27915469
16.
[Development of new treatments for extranodal NK/T-cell lymphoma in Japan].
Rinsho Ketsueki
; 56(6): 639-44, 2015 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-26256873
17.
[Relapse in the nasal cavity of a patient with extranodal NK/T-cell lymphoma initially presenting as plantar subcutaneous tumor].
Rinsho Ketsueki
; 56(8): 1076-81, 2015 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-26345570
18.
Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Cancer Sci
; 105(11): 1435-41, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25181936
19.
[Peripheral T-cell lymphoma/ extranodal NK/T-cell lymphoma, nasal type: PTCL/ENKL].
Rinsho Ketsueki
; 60(3): 245-246, 2019.
Artículo
en Japonés
| MEDLINE | ID: mdl-31068532
20.
[Successful treatment of Bing-Neel syndrome using combination therapy with fludarabine and rituximab].
Rinsho Ketsueki
; 55(12): 2423-8, 2014 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-25744044